Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
7
×
clinical trials
7
×
eli lilly
7
×
fda
7
×
life sciences
national blog main
san francisco blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
startups
bristol-myers squibb
cancer immunotherapy
merck
moderna
pfizer
abbvie
alzheimer's disease
black diamond therapeutics
What
bio
roundup
companies
black
drug
week
biotech
cancer
diamond
diamond’s
growing
ipo
leading
life
research
science
therapeutics
alliance
alzheimer’s
annual
appetite
approved
arena’s
assessed
attention
bounty
bread
bristol
butter
buy
buyout
calls
cash
changing
cig
clinic
color
comeback
communities
conference
Language
unset
Current search:
fda
×
" clinical trials "
×
" eli lilly "
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More